Bariata, Pedro A.

HRN: 23-35-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/15/2023
07/21/2023
IV
1.5gram
Q6hr
Non-healing Wound, Both Feer; DM TYPE II UNCONTROLLED
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: